Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Declares Non-Reliance on Past Financials, Citing Material Weaknesses

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.578
Mkt Cap
$65.511M
52W Low
$0.54
52W High
$2.69
52W Position info
7.0% above low
Off High info
79% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ARAY is trading near its 52-week low of $0.54 (7.0% above the low).

Summary

Accuray Inc. announced that its previously issued financial statements and auditor's report for fiscal year 2025 and Q1 FY2026 should no longer be relied upon due to errors in RPO disclosure and identified material weaknesses in internal controls.


Key Events · Corporate Governance and Compliance · ARAY

  • Non-Reliance on Financial Statements

    The Audit Committee concluded that previously issued audited financial statements for FY2025 and unaudited interim statements for FY2025 and Q1 FY2026, along with the auditor's report, should no longer be relied upon.

  • Disclosure Errors Identified

    Errors were discovered in the disclosure of remaining performance obligations (RPO) due to an incorrect methodology for classifying open system and upgrade sales orders, though these errors are not expected to impact core financial statements.

  • Material Weaknesses in Controls

    The company identified material weaknesses in its internal control over financial reporting (ICFR) and disclosure controls and procedures (DCP) as of June 30, 2025, stemming from the incorrect assessment during the initial adoption of ASC 606.

  • Amended Filings Planned

    Accuray will file Form 10-K/A for FY2025 and Form 10-Q/A for Q1 FY2026 to correct the errors and detail remediation plans for the identified material weaknesses.


Analysis · ARAY · Industrial Applications And Services

This 8-K filing signals a significant breakdown in Accuray's financial reporting and internal controls, coming shortly after the company received a Nasdaq delisting notice and reported substantial financial losses. While the company states the errors do not impact core financial statements, the declaration of non-reliance on past financials and the identification of material weaknesses in internal control over financial reporting (ICFR) and disclosure controls and procedures (DCP) are severe red flags. This raises serious concerns about the reliability of the company's financial disclosures and its governance, further compounding investor uncertainty amidst existing operational and compliance challenges. The company plans to file amended reports to correct these issues.

At the time of this filing, ARAY was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $65.5M. The 52-week trading range was $0.54 to $2.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.253 info
Change: -$0.1125 (-31%) info
Market Cap: $28.956M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.253 info
Change: -$0.0547 (-18%) info
Market Cap: $28.956M info
ARAY
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4105
Real-time Price: $0.253 info
Change: -$0.1575 (-38%) info
Market Cap: $28.956M info
ARAY
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4724
Real-time Price: $0.253 info
Change: -$0.2194 (-46%) info
Market Cap: $28.956M info
ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4455
Real-time Price: $0.253 info
Change: -$0.1925 (-43%) info
Market Cap: $28.956M info